Medigard Pharmaceuticals Private Limited
About Medigard Pharmaceuticals Private Limited
Data last updated:
Medigard Pharmaceuticals Private Limited is a private limited company based in Thiruvananthapuram, Kerala, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 16 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24233KL2007PTC020505. Its GSTIN is 32AAKCM0436F1ZV (Kerala).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Ajithkumar Lalitha Madhavan (Managing Director) and Kalaiselvi Perumal Velautha (Director Appointed In Casual Vacancy).
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at B P 1/1522 Thempamuttom Russelpuram P.O, Thiruvananthapuram, Kerala, India – 695501.
As per the financials filed for FY 2023, the company reported a revenue of ₹24.14 Lakh, a growth of 77% compared to the previous year. For the same year it recorded a net loss of ₹5.82 Lakh (net margin -24.1%) and EBITDA of -₹5.81 Lakh (EBITDA margin -24.1%). Revenue has grown at a compounded annual rate (CAGR) of 102% over three years and 102% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medigard Pharmaceuticals Private Limited's registered office is in Thiruvananthapuram, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB P 1/1522 Thempamuttom Russelpuram P.O, Thiruvananthapuram, Kerala, India – 695501
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Medigard Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medigard Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medigard Pharmaceuticals Private Limited, buy the company report.
Financials of Medigard Pharmaceuticals Private Limited
FY 2023 filings availableMedigard Pharmaceuticals Private Limited reported revenue of ₹24.14 Lakh (up 77% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 102% over five years, including 77% growth in the latest year. EBITDA fell 435% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -24.1% | ||||
| Net Profit Margin | -24.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medigard Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medigard Pharmaceuticals Private Limited
Medigard Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kalaiselvi Perumal Velautha | Director Appointed In Casual Vacancy | 21 Oct 2015 | 11 Years 0 Months | Current |
| Ajithkumar Lalitha Madhavan | Managing Director | 16 Mar 2007 | 19 Years 7 Months | Current |
Auditor
Medigard Pharmaceuticals Private Limited is audited by S SURESH BABU AND ASSOCIATE for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S SURESH BABU AND ASSOCIATE | FY 2017 | 202893 |
Shareholding
The shareholding of Medigard Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Medigard Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medigard Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medigard Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medigard Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAKCM0436F1ZV | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medigard Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medigard Pharmaceuticals Private Limited has 4 board changes on record since 2007: 2 appointments and 2 cessations. The latest: Kalaiselvi Perumal Velautha was appointed as Director Appointed In Casual Vacancy on 21 Oct 2015.
Frequently asked questions
Medigard Pharmaceuticals is an active private limited company based in Thiruvananthapuram, Kerala, India. The company works in chemical products, within the chemicals industry. It was incorporated on 16 March 2007 (19+ years old) and is registered under CIN U24233KL2007PTC020505.
Medigard Pharmaceuticals has 2 current directors:
- Ajithkumar Lalitha Madhavan - Managing Director
- Kalaiselvi Perumal Velautha - Director Appointed In Casual Vacancy
The latest financial statements of Medigard Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Medigard Pharmaceuticals is 32AAKCM0436F1ZV, registered in Kerala.
The CIN (Corporate Identification Number) of Medigard Pharmaceuticals is U24233KL2007PTC020505. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medigard Pharmaceuticals was incorporated on 16 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ernakulam.
Kalaiselvi Perumal Velautha was appointed as Director Appointed In Casual Vacancy on 21 Oct 2015. Kuruvila Samuel ceased to be Director on 21 Oct 2015. Lalitha Kesavan ceased to be Director on 13 Feb 2013. Medigard Pharmaceuticals has 4 board changes on record in total.
The registered office of Medigard Pharmaceuticals is at B P 11522 Thempamuttom Russelpuram P.O, Thiruvananthapuram, Kerala, India – 695501.
Medigard Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
The compliance status of Medigard Pharmaceuticals is compliant as of 14 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
